PR Newswire Clinical TrialsOriginal article
Vector Science & Therapeutics Builds 15-Patent-Application Intellectual Property Portfolio Around Precision Therapeutic Delivery, Anchored by Peptide and Biologic Administration Technologies
Patent ExpiryPositive
AI Analysis
Summary
Vector Science & Therapeutics announced the development of a 15-patent-application intellectual property portfolio focused on precision therapeutic delivery technologies, including peptide and biologic administration, with applications in pain management, oncology, regenerative medicine, and wound care.
Importance:2/10
Sentiment:
0.30
intellectual propertydrug deliverypeptide therapeuticsbiologic deliverypatent applications
Read the original article
Published by PR Newswire Clinical Trials on July 15, 2026 11:50 AM
